Literature DB >> 2266810

Severe anaphylactoid reaction after i.v. Gd-DTPA.

K L Weiss1.   

Abstract

Serious adverse reactions following the IV administration of Gd-DTPA (Magnevist, gadopenetate dimeglumine, Berlex Laboratories, Wayne, NJ), although extremely rare, can occur. As yet, there has been no published case of a severe anaphylactoid-type reaction to Gd-DTPA.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2266810     DOI： 10.1016/0730-725x(90)90019-x

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN： 0730-725X            Impact factor:   2.546


  4 in total

1.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Authors:  D H Miller; F Barkhof; I Berry; L Kappos; G Scotti; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

2.  Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA).

Authors:  P Brugières; A Gaston; H R Degryse; P M Parizel; A M de Schepper; I Berry; C Manelfe; F Le Bras; C Marsault; W Wichmann
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

3.  Incidental MRI findings of acute gadolinium hypersensitivity.

Authors:  C Amene; L A Yeh-Nayre; C E Dory; J R Crawford
Journal:  Case Rep Neurol       Date:  2012-04-24

4.  Hypersensitivity to Gadolinium-Based Contrast Media.

Authors:  M Teresa Gracia Bara; Alicia Gallardo-Higueras; Esther M Moreno; Elena Laffond; Francisco J Muñoz Bellido; Cristina Martin; Miriam Sobrino; Eva Macias; Sonia Arriba-Méndez; Rosita Castillo; Ignacio Davila
Journal:  Front Allergy       Date:  2022-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.